HSPG2 and cancer: The signal transduction mechanisms activated by GnRH in gonadotrophic cells of the pituitary were not turned on by GnRH agonists in cancers of the ovary, endometrium, and breast even though activation of PLC, PKC, and AC in cells of these cancers by pharmacological stimulation was clearly shown (23, 47).